Dosimetric Comparison of Helical Tomotherapy and Intensity-Modulated Proton Therapy in Hippocampus- and Scalp-Sparing Whole Brain Radiotherapy

Objective: Cognitive decline and alopecia after radiotherapy are challenging problems. We aimed to compare whole brain radiotherapy (WBRT) plans reducing radiation dose to the hippocampus and scalp between helical tomotherapy (HT) and intensity-modulated proton therapy (IMPT). Methods: We conducted...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Taiki Takaoka MD, PhD, Natsuo Tomita MD, PhD, Tomoki Mizuno MD, Shingo Hashimoto MD, PhD, Takahiro Tsuchiya RTT, Masashi Tomida RTT, Takeshi Yanagi MD, PhD
Formato: article
Lenguaje:EN
Publicado: SAGE Publishing 2021
Materias:
Acceso en línea:https://doaj.org/article/fbd740828d5841df9c70ca2967098239
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fbd740828d5841df9c70ca2967098239
record_format dspace
spelling oai:doaj.org-article:fbd740828d5841df9c70ca29670982392021-11-21T02:04:14ZDosimetric Comparison of Helical Tomotherapy and Intensity-Modulated Proton Therapy in Hippocampus- and Scalp-Sparing Whole Brain Radiotherapy1533-033810.1177/15330338211060170https://doaj.org/article/fbd740828d5841df9c70ca29670982392021-11-01T00:00:00Zhttps://doi.org/10.1177/15330338211060170https://doaj.org/toc/1533-0338Objective: Cognitive decline and alopecia after radiotherapy are challenging problems. We aimed to compare whole brain radiotherapy (WBRT) plans reducing radiation dose to the hippocampus and scalp between helical tomotherapy (HT) and intensity-modulated proton therapy (IMPT). Methods: We conducted a planning study of WBRT for 10 patients. The clinical target volume was defined as the whole brain excluding the hippocampus avoidance (HA) region. The prescribed dose was 30 Gy in 10 fractions to cover 95% of the target. Constraint goals were defined for the target and organs at risk (OAR). Results: Both techniques met the dose constraints for the target and OAR. However, the coverage of the target (dose covering 95% [D95%] and 98% [D98%] of the volume) were better in IMPT than HT (HT vs IMPT: D95%, 29.9 Gy vs 30.0 Gy, P  < .001; D98%, 26.7 Gy vs 28.1 Gy, P  = .002). The homogeneity and conformity of the target were also better in IMPT than HT (HT vs IMPT: homogeneity index, 1.50 vs 1.28, P  < .001; conformity index, 1.30 vs 1.14, P  < .001). IMPT reduced the D100% of the hippocampus by 59% (HT vs IMPT: 9.3 Gy vs 3.8 Gy, P  < .001) and reduced the Dmean of the hippocampus by 37% (HT vs IMPT: 11.1 Gy vs 7.0 Gy, P  < .001) compared with HT. The scalp IMPT reduced the percentage of the volume receiving at least 20 Gy (V20Gy) and V10Gy compared with HT (HT vs IMPT: V20Gy, 56.7% vs 6.6%, P  < .001; V10Gy, 90.5% vs 37.1%, P  < .001). Conclusion: Both techniques provided acceptable target dose coverage. Especially, IMPT achieved excellent hippocampus- and scalp-sparing. HA-WBRT using IMPT is a promising treatment to prevent cognitive decline and alopecia.Taiki Takaoka MD, PhDNatsuo Tomita MD, PhDTomoki Mizuno MDShingo Hashimoto MD, PhDTakahiro Tsuchiya RTTMasashi Tomida RTTTakeshi Yanagi MD, PhDSAGE PublishingarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENTechnology in Cancer Research & Treatment, Vol 20 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Taiki Takaoka MD, PhD
Natsuo Tomita MD, PhD
Tomoki Mizuno MD
Shingo Hashimoto MD, PhD
Takahiro Tsuchiya RTT
Masashi Tomida RTT
Takeshi Yanagi MD, PhD
Dosimetric Comparison of Helical Tomotherapy and Intensity-Modulated Proton Therapy in Hippocampus- and Scalp-Sparing Whole Brain Radiotherapy
description Objective: Cognitive decline and alopecia after radiotherapy are challenging problems. We aimed to compare whole brain radiotherapy (WBRT) plans reducing radiation dose to the hippocampus and scalp between helical tomotherapy (HT) and intensity-modulated proton therapy (IMPT). Methods: We conducted a planning study of WBRT for 10 patients. The clinical target volume was defined as the whole brain excluding the hippocampus avoidance (HA) region. The prescribed dose was 30 Gy in 10 fractions to cover 95% of the target. Constraint goals were defined for the target and organs at risk (OAR). Results: Both techniques met the dose constraints for the target and OAR. However, the coverage of the target (dose covering 95% [D95%] and 98% [D98%] of the volume) were better in IMPT than HT (HT vs IMPT: D95%, 29.9 Gy vs 30.0 Gy, P  < .001; D98%, 26.7 Gy vs 28.1 Gy, P  = .002). The homogeneity and conformity of the target were also better in IMPT than HT (HT vs IMPT: homogeneity index, 1.50 vs 1.28, P  < .001; conformity index, 1.30 vs 1.14, P  < .001). IMPT reduced the D100% of the hippocampus by 59% (HT vs IMPT: 9.3 Gy vs 3.8 Gy, P  < .001) and reduced the Dmean of the hippocampus by 37% (HT vs IMPT: 11.1 Gy vs 7.0 Gy, P  < .001) compared with HT. The scalp IMPT reduced the percentage of the volume receiving at least 20 Gy (V20Gy) and V10Gy compared with HT (HT vs IMPT: V20Gy, 56.7% vs 6.6%, P  < .001; V10Gy, 90.5% vs 37.1%, P  < .001). Conclusion: Both techniques provided acceptable target dose coverage. Especially, IMPT achieved excellent hippocampus- and scalp-sparing. HA-WBRT using IMPT is a promising treatment to prevent cognitive decline and alopecia.
format article
author Taiki Takaoka MD, PhD
Natsuo Tomita MD, PhD
Tomoki Mizuno MD
Shingo Hashimoto MD, PhD
Takahiro Tsuchiya RTT
Masashi Tomida RTT
Takeshi Yanagi MD, PhD
author_facet Taiki Takaoka MD, PhD
Natsuo Tomita MD, PhD
Tomoki Mizuno MD
Shingo Hashimoto MD, PhD
Takahiro Tsuchiya RTT
Masashi Tomida RTT
Takeshi Yanagi MD, PhD
author_sort Taiki Takaoka MD, PhD
title Dosimetric Comparison of Helical Tomotherapy and Intensity-Modulated Proton Therapy in Hippocampus- and Scalp-Sparing Whole Brain Radiotherapy
title_short Dosimetric Comparison of Helical Tomotherapy and Intensity-Modulated Proton Therapy in Hippocampus- and Scalp-Sparing Whole Brain Radiotherapy
title_full Dosimetric Comparison of Helical Tomotherapy and Intensity-Modulated Proton Therapy in Hippocampus- and Scalp-Sparing Whole Brain Radiotherapy
title_fullStr Dosimetric Comparison of Helical Tomotherapy and Intensity-Modulated Proton Therapy in Hippocampus- and Scalp-Sparing Whole Brain Radiotherapy
title_full_unstemmed Dosimetric Comparison of Helical Tomotherapy and Intensity-Modulated Proton Therapy in Hippocampus- and Scalp-Sparing Whole Brain Radiotherapy
title_sort dosimetric comparison of helical tomotherapy and intensity-modulated proton therapy in hippocampus- and scalp-sparing whole brain radiotherapy
publisher SAGE Publishing
publishDate 2021
url https://doaj.org/article/fbd740828d5841df9c70ca2967098239
work_keys_str_mv AT taikitakaokamdphd dosimetriccomparisonofhelicaltomotherapyandintensitymodulatedprotontherapyinhippocampusandscalpsparingwholebrainradiotherapy
AT natsuotomitamdphd dosimetriccomparisonofhelicaltomotherapyandintensitymodulatedprotontherapyinhippocampusandscalpsparingwholebrainradiotherapy
AT tomokimizunomd dosimetriccomparisonofhelicaltomotherapyandintensitymodulatedprotontherapyinhippocampusandscalpsparingwholebrainradiotherapy
AT shingohashimotomdphd dosimetriccomparisonofhelicaltomotherapyandintensitymodulatedprotontherapyinhippocampusandscalpsparingwholebrainradiotherapy
AT takahirotsuchiyartt dosimetriccomparisonofhelicaltomotherapyandintensitymodulatedprotontherapyinhippocampusandscalpsparingwholebrainradiotherapy
AT masashitomidartt dosimetriccomparisonofhelicaltomotherapyandintensitymodulatedprotontherapyinhippocampusandscalpsparingwholebrainradiotherapy
AT takeshiyanagimdphd dosimetriccomparisonofhelicaltomotherapyandintensitymodulatedprotontherapyinhippocampusandscalpsparingwholebrainradiotherapy
_version_ 1718419401306275840